GoodRx Holdings, Inc.GDRX

Market cap

$992.93M

P/E ratio

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	551	745	767	750	792
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	30	47	65	67	48
Research and Development Expense	62	126	143	136	124
Sales and marketing	255	370	358	341	367
General and administrative	461	155	145	126	118
Depreciation and amortization	18	35	54	108	70
Total costs and operating expenses	826	732	765	777	726
Operating income (loss)	-276	13	2	-27	66
Other expense	0	-	-	-4	-3
Loss on extinguishment of debt	-	-	-	-	-2
Interest income	0	0	9	32	23
Interest expense	-	-	-	-	53
Total other expense, net	-28	-24	-25	-29	-34
Income (loss) before income taxes	-303	-10	-23	-56	31
Income tax (expense) benefit	-10	15	10	-47	15
Net income (loss)	-294	-25	-33	-9	16
Basic (in usd per share)	-1.07	-0.06	-0.08	-0.02	0.04
Diluted (in usd per share)	-1.07	-0.06	-0.08	-0.02	0.04
Cost of revenue	0	1	0	1	0
Product development and technology	11	35	35	30	25
Sales and marketing	9	21	21	20	33
General and administrative	377	104	64	54	41